About this trial

The aim of this study is to demonstrate that cerebral blood flow and brain function do not resume after death declaration in organ donors who undergo normothermic regional perfusion to restore organ function following death determination by circulatory criteria, when appropriate safeguards are applied.

To assess the absence of cerebral perfusion and function, investigators will use continuous and comprehensive multimodal neuromonitoring throughout the withdrawal of life-sustaining therapies, the dying process and the NRP procedure.

Eligibility criteria

Qualifiers

Age > 18;

Planned DCD within the next 96 hours.

Disqualifiers

Coagulopathy (International normalized ratio > 1.5, prothrombin time > 45 seconds, platelets < 50);

Therapeutic anticoagulant medication administration.

Trial design

Treatments tested in this trial

  • Neuromonitoring

Treatment groups

30 Participants
are divided into 1 treatment group

Locations

1
Vancouver General HospitalV5Z1M9, VancouverBritish Columbia, Canada

Sponsors and collaborators

University of British Columbia

Lead sponsor